JB Chemicals & Pharmaceuticals Ltd has announced the audited financial results for the quarter & year ended March 31, 2007. The results for the Quarter ended March 31, 2007 are as follows: The Company has posted a profit after tax of Rs 109.251 million for the quarter ended March 31, 2007 where as the same was at Rs 154.577 million for the quarter ended March 31, 2006. Total Income (net of excise) is Rs 1458.516 million for the quarter ended March 31, 2007 where as the same was at Rs 1170.732 million for the quarter ended March 31, 2006.
The results for the Year ended March 31, 2007 are as follows: The Company has posted a profit after tax of Rs 710.228 million for the year ended March 31, 2007 where as the same was at Rs 709.278 million for the year ended March 31, 2006. Total Income (net of excise) is Rs 5421.570 million for the year ended March 31, 2007 where as the same was at Rs 4775.525 million for the year ended March 31, 2006.
The consolidated results for the Year ended March 31, 2007 are as follows: The group has posted a net profit attributable to parent of Rs 621.772 million for the year ended March 31, 2007 where as the same was at Rs 702.371 million for the year ended March 31, 2006. Total Income (net of excise) is Rs 5364.579 million for the year ended March 31, 2007 where as the same was at Rs 4771.231 million for the year ended March 31, 2006.
The Hon'ble High Court of Judicature of Bombay, at Mumbai sanctioned the Scheme of Amalgamation of Lekar Healthcare Ltd. (LHL) a wholly owned subsidiary of the Company, with the Company on February 02, 2007. Accordingly, on filing of the said order with the Registrar of Companies, Maharashtra, Mumbai, the Scheme of Amalgamation became effective from April 01, 2006, the appointed date.
In view of the said Amalgamation the annual accounts include the figures of LHL. Hence, the figures for the fourth quarter as well as the current year are not comparable with the similar period of the previous year.